| 1E8Y | A:357-522 | STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN, LY294002, QUERCETIN, MYRICETIN AND STAUROSPORINE |
| 1E8Z | A:357-522 | STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN, LY294002, QUERCETIN, MYRICETIN AND STAUROSPORINE |
| 1HE8 | A:353-524 | RAS G12V - PI 3-KINASE GAMMA COMPLEX |
| 2A4Z | A:357-522 | CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS604850 |
| 2A5U | A:357-522 | CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS605240 |
| 2CHW | A:357-522 | A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110 ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-39 |
| 2CHX | A:357-522 | A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-90 |
| 2CHZ | A:357-522 | A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-93 |
| 2V4L | A:357-522 | COMPLEX OF HUMAN PHOSPHOINOSITIDE 3-KINASE CATALYTIC SUBUNIT GAMMA (P110 GAMMA) WITH PIK-284 |
| 3APC | A:357-521 | CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5132799 |
| 3APD | A:357-522 | CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5108134 |
| 3APF | A:357-522 | CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5039699 |
| 3CSF | A:357-522 | CRYSTAL STRUCTURE OF PI3K P110GAMMA CATALYTICAL DOMAIN IN COMPLEX WITH ORGANORUTHENIUM INHIBITOR DW2 |
| 3DPD | A:357-522 | ACHIEVING MULTI-ISOFORM PI3K INHIBITION IN A SERIES OF SUBSTITUTED 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINES |
| 3ENE | A:357-522 | COMPLEX OF PI3K GAMMA WITH AN INHIBITOR |
| 3IBE | A:357-522 | CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR BOUND TO PI3 KINASE GAMMA |
| 3L08 | A:352-520 | STRUCTURE OF PI3K GAMMA WITH A POTENT INHIBITOR: GSK2126458 |
| 3L13 | A:357-522 | CRYSTAL STRUCTURES OF PAN-PI3-KINASE AND DUAL PAN-PI3-KINASE/MTOR INHIBITORS |
| 3L16 | A:357-522 | DISCOVERY OF (THIENOPYRIMIDIN-2-YL)AMINOPYRIMIDINES AS POTENT, SELECTIVE, AND ORALLY AVAILABLE PAN-PI3-KINASE AND DUAL PAN-PI3-KINASE/MTOR INHIBITORS FOR THE TREATMENT OF CANCER |
| 3L17 | A:357-522 | DISCOVERY OF (THIENOPYRIMIDIN-2-YL)AMINOPYRIMIDINES AS POTENT, SELECTIVE, AND ORALLY AVAILABLE PAN-PI3-KINASE AND DUAL PAN-PI3-KINASE/MTOR INHIBITORS FOR THE TREATMENT OF CANCER |
| 3LJ3 | A:357-522 | PI3-KINASE-GAMMA WITH A PYRROLOPYRIDINE-BENZOFURAN INHIBITOR |
| 3MJW | A:357-522 | PI3 KINASE GAMMA WITH A BENZOFURANONE INHIBITOR |
| 3ML8 | A:357-522 | DISCOVERY OF THE HIGHLY POTENT PI3K/MTOR DUAL INHIBITOR PF-04691502 THROUGH STRUCTURE BASED DRUG DESIGN |
| 3ML9 | A:357-522 | DISCOVERY OF THE HIGHLY POTENT PI3K/MTOR DUAL INHIBITOR PF-04691502 THROUGH STRUCTURE BASED DRUG DESIGN |
| 3NZS | A:353-521 | STRUCTURE-BASED OPTIMIZATION OF PYRAZOLO -PYRIMIDINE AND -PYRIDINE INHIBITORS OF PI3-KINASE |
| 3NZU | A:357-521 | STRUCTURE-BASED OPTIMIZATION OF PYRAZOLO -PYRIMIDINE AND -PYRIDINE INHIBITORS OF PI3-KINASE |
| 3OAW | A:353-524 | 4-METHYLPTERIDINEONES AS ORALLY ACTIVE AND SELECTIVE PI3K/MTOR DUAL INHIBITORS |
| 3PRE | A:353-522 | QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS. |
| 3PRZ | A:352-524 | QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS. |
| 3PS6 | A:352-523 | QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS. |
| 3QAQ | A:352-522 | CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH TRIAZINE-BENZIMIDAZOLE 1 |
| 3QAR | A:353-522 | CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH TRIAZINE-BENZIMIDAZOLE 32 |
| 3QK0 | A:357-522 | CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH BENZOTHIAZOLE 82 |
| 3S2A | A:352-522 | CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH A QUINOLINE INHIBITOR |
| 3TJP | A:357-522 | CRYSTAL STRUCTURE OF PI3K GAMMA WITH N6-(3,4-DIMETHOXYPHENYL)-2-MORPHOLINO-[4,5'-BIPYRIMIDINE]-2',6-DIAMINE |
| 3TL5 | A:357-524 | DISCOVERY OF GDC-0980: A POTENT, SELECTIVE, AND ORALLY AVAILABLE CLASS I PHOSPHATIDYLINOSITOL 3-KINASE (PI3K)/MAMMALIAN TARGET OF RAPAMYCIN (MTOR) KINASE INHIBITOR FOR THE TREATMENT OF CANCER |
| 4DK5 | A:352-522 | CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH A PYRIDYL-TRIAZINE INHIBITOR |
| 4EZJ | A:357-522 | POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF |
| 4EZK | A:357-522 | POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF |
| 4EZL | A:357-522 | POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF |
| 4F1S | A:352-522 | CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH A PYRIDYL-TRIAZINE-SULFONAMIDE INHIBITOR |
| 4FHJ | A:357-522 | CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH IMIDAZOPYRIDINE 2 |
| 4FHK | A:357-522 | CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH IMIDAZOPYRIDAZINE 19E |
| 4FJY | A:352-522 | CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH QUINOLINE-INDOLINE INHIBITOR 24F |
| 4FJZ | A:356-522 | CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH PYRROLO-PYRIDINE INHIBITOR 63 |
| 4FLH | A:352-521 | CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH AMG511 |
| 4FUL | A:357-522 | PI3 KINASE GAMMA BOUND TO A PYRMIDINE INHIBITOR |
| 4GB9 | A:357-522 | POTENT AND HIGHLY SELECTIVE BENZIMIDAZOLE INHIBITORS OF PI3K-DELTA |
| 4HVB | A:357-522 | CATALYTIC UNIT OF PI3KG IN COMPLEX WITH PI3K/MTOR DUAL INHIBITOR PF-04979064 |
| 4KZ0 | A:357-522 | STRUCTURE OF PI3K GAMMA WITH IMIDAZOPYRIDINE INHIBITORS |
)
)